Assessing the quality of evidence for preterm labor tocolytic trials

David Haas, Page Kirkpatrick, Jennifer J. McIntosh, Deborah M. Caldwell

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective: To assess the quality of tocolysis randomized controlled trials (RCTs) and to determine trial factors contributing to better quality evidence. Methods: The Cochrane Central Register of Controlled Trials, MEDLINE, MEDLINE In-Process, EMBASE and CINAHL were searched for terms preterm labor, tocolytic or obstetric labor, premature up to 1 August 2009.Data regarding study design, characteristics, number of participants and outcomes reported were extracted by at least two review authors. Study quality was assigned using the Cochrane Collaboration Handbook methodology and categories. Trends for quality over time, the impact of study size and the individual drugs compared were analyzed for impact on overall quality of trials. Results: Of the 3197 titles initially identified, 89 RCTs of tocolytic therapy were reviewed. Of the six quality areas, 10 (11.2%) trials satisfied all areas, while only one trial (1.1%) met one area. The mean number of adequate areas was 4.1 ± 1.2. Overall, 52 (58.4%) of the trials achieved high-quality categorization. Controlling for multiple trial factors, the trial continent and decade were significant predictors of overall trial quality. Conclusion: The majority of tocolysis RCTs are of high quality. Larger trials, more recent trials and placebo-controlled trials were associated with higher quality scores.

Original languageEnglish
Pages (from-to)1646-1652
Number of pages7
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume25
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Tocolytic Agents
Tocolysis
Premature Obstetric Labor
Randomized Controlled Trials
MEDLINE
Placebos
Pharmaceutical Preparations

Keywords

  • Methodological quality
  • Randomized trials
  • Systematic review
  • Tocolysis

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology

Cite this

Assessing the quality of evidence for preterm labor tocolytic trials. / Haas, David; Kirkpatrick, Page; McIntosh, Jennifer J.; Caldwell, Deborah M.

In: Journal of Maternal-Fetal and Neonatal Medicine, Vol. 25, No. 9, 09.2012, p. 1646-1652.

Research output: Contribution to journalArticle

Haas, David ; Kirkpatrick, Page ; McIntosh, Jennifer J. ; Caldwell, Deborah M. / Assessing the quality of evidence for preterm labor tocolytic trials. In: Journal of Maternal-Fetal and Neonatal Medicine. 2012 ; Vol. 25, No. 9. pp. 1646-1652.
@article{0b256f00ad6148b8961672a1a92a4768,
title = "Assessing the quality of evidence for preterm labor tocolytic trials",
abstract = "Objective: To assess the quality of tocolysis randomized controlled trials (RCTs) and to determine trial factors contributing to better quality evidence. Methods: The Cochrane Central Register of Controlled Trials, MEDLINE, MEDLINE In-Process, EMBASE and CINAHL were searched for terms preterm labor, tocolytic or obstetric labor, premature up to 1 August 2009.Data regarding study design, characteristics, number of participants and outcomes reported were extracted by at least two review authors. Study quality was assigned using the Cochrane Collaboration Handbook methodology and categories. Trends for quality over time, the impact of study size and the individual drugs compared were analyzed for impact on overall quality of trials. Results: Of the 3197 titles initially identified, 89 RCTs of tocolytic therapy were reviewed. Of the six quality areas, 10 (11.2{\%}) trials satisfied all areas, while only one trial (1.1{\%}) met one area. The mean number of adequate areas was 4.1 ± 1.2. Overall, 52 (58.4{\%}) of the trials achieved high-quality categorization. Controlling for multiple trial factors, the trial continent and decade were significant predictors of overall trial quality. Conclusion: The majority of tocolysis RCTs are of high quality. Larger trials, more recent trials and placebo-controlled trials were associated with higher quality scores.",
keywords = "Methodological quality, Randomized trials, Systematic review, Tocolysis",
author = "David Haas and Page Kirkpatrick and McIntosh, {Jennifer J.} and Caldwell, {Deborah M.}",
year = "2012",
month = "9",
doi = "10.3109/14767058.2011.650249",
language = "English",
volume = "25",
pages = "1646--1652",
journal = "Journal of Maternal-Fetal and Neonatal Medicine",
issn = "1476-7058",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Assessing the quality of evidence for preterm labor tocolytic trials

AU - Haas, David

AU - Kirkpatrick, Page

AU - McIntosh, Jennifer J.

AU - Caldwell, Deborah M.

PY - 2012/9

Y1 - 2012/9

N2 - Objective: To assess the quality of tocolysis randomized controlled trials (RCTs) and to determine trial factors contributing to better quality evidence. Methods: The Cochrane Central Register of Controlled Trials, MEDLINE, MEDLINE In-Process, EMBASE and CINAHL were searched for terms preterm labor, tocolytic or obstetric labor, premature up to 1 August 2009.Data regarding study design, characteristics, number of participants and outcomes reported were extracted by at least two review authors. Study quality was assigned using the Cochrane Collaboration Handbook methodology and categories. Trends for quality over time, the impact of study size and the individual drugs compared were analyzed for impact on overall quality of trials. Results: Of the 3197 titles initially identified, 89 RCTs of tocolytic therapy were reviewed. Of the six quality areas, 10 (11.2%) trials satisfied all areas, while only one trial (1.1%) met one area. The mean number of adequate areas was 4.1 ± 1.2. Overall, 52 (58.4%) of the trials achieved high-quality categorization. Controlling for multiple trial factors, the trial continent and decade were significant predictors of overall trial quality. Conclusion: The majority of tocolysis RCTs are of high quality. Larger trials, more recent trials and placebo-controlled trials were associated with higher quality scores.

AB - Objective: To assess the quality of tocolysis randomized controlled trials (RCTs) and to determine trial factors contributing to better quality evidence. Methods: The Cochrane Central Register of Controlled Trials, MEDLINE, MEDLINE In-Process, EMBASE and CINAHL were searched for terms preterm labor, tocolytic or obstetric labor, premature up to 1 August 2009.Data regarding study design, characteristics, number of participants and outcomes reported were extracted by at least two review authors. Study quality was assigned using the Cochrane Collaboration Handbook methodology and categories. Trends for quality over time, the impact of study size and the individual drugs compared were analyzed for impact on overall quality of trials. Results: Of the 3197 titles initially identified, 89 RCTs of tocolytic therapy were reviewed. Of the six quality areas, 10 (11.2%) trials satisfied all areas, while only one trial (1.1%) met one area. The mean number of adequate areas was 4.1 ± 1.2. Overall, 52 (58.4%) of the trials achieved high-quality categorization. Controlling for multiple trial factors, the trial continent and decade were significant predictors of overall trial quality. Conclusion: The majority of tocolysis RCTs are of high quality. Larger trials, more recent trials and placebo-controlled trials were associated with higher quality scores.

KW - Methodological quality

KW - Randomized trials

KW - Systematic review

KW - Tocolysis

UR - http://www.scopus.com/inward/record.url?scp=84865480879&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865480879&partnerID=8YFLogxK

U2 - 10.3109/14767058.2011.650249

DO - 10.3109/14767058.2011.650249

M3 - Article

VL - 25

SP - 1646

EP - 1652

JO - Journal of Maternal-Fetal and Neonatal Medicine

JF - Journal of Maternal-Fetal and Neonatal Medicine

SN - 1476-7058

IS - 9

ER -